why choose us

Clinical Trials Search

Showing 7,890 of 132,085 result(s)
Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

Status: ACTIVE_NOT_RECRUITING

Condition: COVID-19

Interventions:

Drug product RQ-001 is the fully assembled device consisting of the vial containing RQ-01 and the actuator.
Drug Product RQ-001 has been devel

Date: 2023-09-17

A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF)

Status: COMPLETED

Condition: Idiopathic Pulmonary Fibrosis

Interventions: REGEND001: 1-1.5×10^6 bronchial basal cells;kg administrated by bronchoscopy.

Date: 2023-09-17

YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis

Status: COMPLETED

Condition: Atherosclerotic Cardiovascular Disease

Interventions: In single ascending dose (SAD) part of study in health subjects, YN001 will be administrated one time with dosage from 10 mg to 120 mg (planned).

Date: 2023-09-16

Anxiety in Relation to Nausea and Vomiting in Pregnancy

Status: COMPLETED

Condition: Nausea Gravidarum

Interventions: The Pregnancy-Unique Quantification of Emesis (PUQE) is a scoring system to quantify the severity of nausea and vomiting of pregnancy (NVP).
Base

Date: 2023-09-16

Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback

Status: NOT_YET_RECRUITING

Condition: Major Depressive Disorder

Interventions:

During the second fMRI, the study will introduce the real time fMRI neurofeedback part of the study.
This is where subjects will use the activ

Date: 2023-09-16

A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy

Status: NOT_YET_RECRUITING

Condition: Varicella

Interventions: single,intramuscular injection

Date: 2023-09-16

A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants

Status: Completed

Condition: Healthy

Interventions: Administered orally

Date: 2023-09-15

A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

Status: Completed

Condition: Colitis, Ulcerative

Interventions: JNJ-77242113 tablet will be administered orally.

Date: 2023-09-15

The Gut Microbiome and Immunotherapy Response in Solid Cancers

Status: Completed

Condition: Cancer

Interventions:

Date: 2023-09-15

Novel Amblyopia Treatment With Virtual Reality Games

Status: Completed

Condition: Amblyopia

Interventions: Optical correction (if needed)

Date: 2023-09-15